First‐in‐Man Study of Dedicated Bifurcation Sirolimus‐eluting Stent: 12‐month Results of BiOSS LIM® Registry

ConclusionDedicated bifurcation stent BiOSS® LIM proved to be feasible device, with promising safety and long‐term clinical effectiveness in the treatment of coronary bifurcation lesions, including distal left main stem stenosis. (J Interven Cardiol 2015;28:51–60)

Source: Journal of Interventional Cardiology - February 16, 2015 Category: Cardiology Authors: ROBERT J. GIL, JACEK BIL, DOBRIN VASSILIEV, LUIS A. IÑIGO GARCIA Tags: Original Investigation Source Type: research